Prediction of Nocturnal Hypoglycemia Following Exercise in Type 1 Diabetes Using Temporally Structured CGM-Derived

Agnese Piersanti1, Gaia Maria Manes1, Libera Lucia Del Giudice1

  • 1Department of Information Engineering, Università Politecnica delle Marche, Via Brecce Bianche 12, 60131 Ancona, Italy.

Insights

Identifying nocturnal hypoglycemia risk in children with type 1 diabetes after exercise is crucial. This study found that specific continuous glucose monitoring (CGM) biomarkers from exercise and recovery periods can predict this risk, aiding safer management.

Area of Science:

  • Endocrinology
  • Biomedical Engineering
  • Pediatric Diabetes Management

Background:

  • Nocturnal hypoglycemia (NH) post-exercise is a significant challenge for pediatric type 1 diabetes (T1D) management.
  • NH occurrence is linked to adverse outcomes and increased caregiver burden in children with T1D.

Purpose of the Study:

  • To identify an interpretable early signature using continuous glucose monitoring (CGM)-derived digital biomarkers for post-exercise NH risk in pediatric T1D.
  • To develop a lightweight, CGM-only decision support tool for safer exercise management in children with T1D.

Main Methods:

  • CGM data from 49 pediatric subjects (DirecNet cohort) were analyzed, extracting metrics from exercise and recovery windows (Exercise + Post-exercise configuration).
  • A Random Forest classifier was employed with feature selection (VIF, mRMR) and class balancing (SMOTE) within a Leave-One-Out Cross Validation framework.
  • The model's generalizability was validated on an independent cohort (OhioT1DM).

Main Results:

  • The Exercise + Post-exercise temporal configuration demonstrated superior performance (BA=76.9%, ROC-AUC=0.75) compared to the Exercise + Cumulative approach.
  • The most robust predictors identified were short-term glucose variability during exercise (CONGA-15_EX), time in hypoglycemia/hyperglycemia, mean absolute glucose change (MAG), and a hypoglycemia risk score (GRADE_hypo).
  • Independent validation confirmed the superior performance of the Exercise + Post-exercise configuration (BA=76.3%, ROC-AUC=0.804).

Conclusions:

  • A concise set of interpretable CGM-derived features from exercise and recovery periods can effectively identify pediatric T1D subjects at risk of nocturnal hypoglycemia.
  • These findings support the development of practical, CGM-only decision support tools to enhance exercise safety for children with T1D.

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...